InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Kassberg Thomas Richard, Directeur Commercial et EVP. Officer active across 1 company, notably Ultragenyx Pharmaceutical Inc.. Aggregated, 10 reports have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €1.3m. Activity tracked since 6 May 2021. The latest transaction was filed on 1 March 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kassberg Thomas Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
18,443 股0Common StockSEC:0000950170-25-032802:0
11,509 股@ US$49.9330.6% 占其流量Common StockSEC:0000950170-24-029780:0
17,800 股0Common StockSEC:0000950170-24-026661:0
39,878 股@ US$6.8614.9% 占其流量Common StockSEC:0001209191-23-053487:0
2,663 股0Common StockSEC:0001209191-23-016046:0
10,281 股@ US$67.010.025% mcap67.0% 占其流量Common StockSEC:0001209191-22-018829:0
2,374 股@ US$66.620.0057% mcap15.1% 占其流量Common StockSEC:0001209191-22-015806:0
286 股@ US$81.141.2% 占其流量Common StockSEC:0001209191-21-060754:0
109,734 股@ US$0.311.8% 占其流量Common StockSEC:0001209191-21-058365:0
363 股@ US$113.692.1% 占其流量Common StockSEC:0001209191-21-031384:0
10 条申报中的 10 条
About Kassberg Thomas Richard
Thomas Richard Kassberg serves as Chief Business Officer and EVP at Ultragenyx Pharmaceutical Inc. In this role, he is responsible for the company's business strategy and growth. Kassberg plays a key role in developing partnerships and expanding markets for Ultragenyx, a biopharmaceutical company specializing in treatments for rare diseases. His expertise in business development is essential for achieving the company's strategic objectives.
